Skip to main content
Fig. 7 | BMC Pharmacology and Toxicology

Fig. 7

From: Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial

Fig. 7

a-d Pre-treatment infection variables and primary clinical outcome. Pearson’s correlation coefficient of treatment outcome of amantadine and placebo on week 7, as based on differences of the Hamilton score of depression (rDHAMD7) and the self-rated well-being scale (DBfS7) after period I, with pre-treatment values of BDV-1 antibodies (maxab) and antigen (maxpag, meanpag), as indicated in parts (a-d)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us